Delivery Order SPE2DB20D2104-SPE2DB24FQ77L
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,495.30 firm fixed-price delivery order is for the supply of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,753.08 firm fixed-price delivery order is for the supply of 4,561,532,318 units of Epinephrine 0.3 mg auto-injectors. The contract has a completion date of July 19, 2023 and was awarded on July 18, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Epinephrine 0.3 mg auto-injectors. The $5,794.65 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of February 5, 2024. Amerisourcebergen is an established pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the Department of Defense and Department of Veterans...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,068.74 for the supply of Epinephrine 0.3 mg auto-injectors. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on January 19, 2022, with a completion date of January 20, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of epinephrine 0.3 mg auto-injectors. The $2,301.53 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 27, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,717.75 firm fixed-price delivery order was issued on March 3, 2022, with a completion date of March 4, 2022. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a defense agency. The $4,135.88 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 1, 2025 with a completion date of May 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,495.30 firm fixed-price delivery order has an ultimate completion date of August 2, 2023. The contract is not designated with a set-aside and was awarded as part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $2,056.59 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 11, 2024. The contract has an ultimate completion date of October 15, 2024 and is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The contract has a ceiling value of $5,454.52 and a completion date of September 7, 2023. This delivery order is not designated as a set-aside contract. Amerisourcebergen...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FQ77LDelivery Order
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver epinephrine 0.3 mg auto-injectors. The $1,794.36 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on October 17, 2023, with an ultimate completion date of October 18, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/17/23 |